Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, offering promising improvements throughout different clinical and industrial purposes. With its structural similarity to Normally derived human serum albumin, OsrHSA provides a safer